- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Repare Therapeutics is a biotechnology business based in the US. Repare Therapeutics shares (RPTX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.48 – a decrease of 3.33% over the previous week. Repare Therapeutics employs 179 staff and has a trailing 12-month revenue of around $68.7 million.
Our top picks for where to buy Repare Therapeutics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Repare Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – RPTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Repare Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Repare Therapeutics stock price (NASDAQ: RPTX)
Use our graph to track the performance of RPTX stocks over time.Repare Therapeutics shares at a glance
Information last updated 2024-10-25.
| Latest market close | $3.48 |
|---|---|
| 52-week range | $2.71 - $8.49 |
| 50-day moving average | $3.23 |
| 200-day moving average | $4.23 |
| Wall St. target price | $13.71 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.63 |
Is it a good time to buy Repare Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Repare Therapeutics price performance over time
Historical closes compared with the close of $3.48 from 2024-10-25
| 1 week (2024-10-21) | -3.33% |
|---|---|
| 1 month (2024-09-27) | 1.16% |
| 3 months (2024-07-26) | -11.68% |
| 6 months (2024-04-26) | 8.75% |
| 1 year (2023-10-27) | 5.45% |
|---|---|
| 2 years (2022-10-28) | -77.71% |
| 3 years (2021-10-28) | 24.89 |
| 5 years (2019-10-24) | N/A |
Repare Therapeutics financials
| Revenue TTM | $68.7 million |
|---|---|
| Gross profit TTM | $15.1 million |
| Return on assets TTM | -22.3% |
| Return on equity TTM | -30.52% |
| Profit margin | -99.76% |
| Book value | $4.80 |
| Market Capitalization | $143 million |
TTM: trailing 12 months
Repare Therapeutics share dividends
We're not expecting Repare Therapeutics to pay a dividend over the next 12 months.
Repare Therapeutics share price volatility
Over the last 12 months, Repare Therapeutics's shares have ranged in value from as little as $2.71 up to $8.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Repare Therapeutics's is 0.715. This would suggest that Repare Therapeutics's shares are less volatile than average (for this exchange).
Repare Therapeutics overview
Repare Therapeutics Inc. , a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validate, and build a pipeline of SL-based therapeutics that focuses on genomic instability, including DNA damage repair. The company's lead product candidate is Camonsertib (RP-3500), an oral small molecule inhibitor under Phase ½ development for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing Lunresertib (RP-6306), a PKMYT1 Inhibitor, which is under Phase I/Ib clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; RP-1664, an oral PLK4 inhibitor, under Phase 1 clinical trial designed to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, a polymerase theta adenosinetriphosphatase (ATPase) inhibitor, a SL target associated with BRCA mutations and other genomic alterations. The company has license and collaboration agreement with Hoffmann-La Roche Inc. and F.
Frequently asked questions
What percentage of Repare Therapeutics is owned by insiders or institutions?Currently 0.955% of Repare Therapeutics shares are held by insiders and 87.018% by institutions. How many people work for Repare Therapeutics?
Latest data suggests 179 work at Repare Therapeutics. When does the fiscal year end for Repare Therapeutics?
Repare Therapeutics's fiscal year ends in December. Where is Repare Therapeutics based?
Repare Therapeutics's address is: 7171 Frederick-Banting, Building 2, Montreal, QC, Canada, H4S 1Z9 What is Repare Therapeutics's ISIN number?
Repare Therapeutics's international securities identification number is: US7602731025
More resources on Finder
More guides on Finder
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question